Terechin Olga, Johansen Paul M, Rosen Adam R, Morgan Matthew, Fraenkel Liana
Berkshire Medical Center, United States.
J Community Hosp Intern Med Perspect. 2023 Sep 2;13(5):90-93. doi: 10.55729/2000-9666.1235. eCollection 2023.
Alcohol use disorder is associated with high morbidity and mortality rates, leading to a significant burden worldwide. Increased hazardous alcohol consumption has been reported during the COVID-19 pandemic raising concerns for greater impact of this already prevalent serious medical condition.
We conducted chart reviews and described demographic and clinical data for patients with two or more hospital readmissions from June 2020 to July 2021 and followed survival status through June 2022.
We found a high mortality rate of 10.3%. Most patients had psychiatric conditions listed in the chart (n = 70, 80%). Only 34% (n = 24) of living patients and 6% (n = 1) of deceased patients were under psychiatric care. Rates of the utilization of medications for alcohol use disorder were low (n = 23, 26%).
We found high mortality rates in patients with two or more hospital readmissions with low rates of utilization of medications for alcohol use disorder and psychiatric care, thus identifying areas of potential improvement.
酒精使用障碍与高发病率和死亡率相关,给全球带来了沉重负担。据报道,在新冠疫情期间,危险饮酒量有所增加,这引发了人们对这种已普遍存在的严重疾病产生更大影响的担忧。
我们进行了病历审查,并描述了2020年6月至2021年7月期间两次或更多次住院再入院患者的人口统计学和临床数据,并跟踪了截至2022年6月的生存状况。
我们发现死亡率高达10.3%。大多数患者的病历中列出了精神疾病(n = 70,80%)。在存活患者中,只有34%(n = 24)接受精神科护理,在死亡患者中这一比例为6%(n = 1)。用于酒精使用障碍的药物使用率较低(n = 23,26%)。
我们发现两次或更多次住院再入院患者的死亡率很高,用于酒精使用障碍的药物使用率和精神科护理率较低,从而确定了潜在的改进领域。